Coya Therapeutics, Common Stock Probability of Future Stock Price Finishing Over 25.45

COYA Stock   6.09  0.05  0.83%   
Coya Therapeutics,'s future price is the expected price of Coya Therapeutics, instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Coya Therapeutics, Common performance during a given time horizon utilizing its historical volatility. Check out Coya Therapeutics, Backtesting, Coya Therapeutics, Valuation, Coya Therapeutics, Correlation, Coya Therapeutics, Hype Analysis, Coya Therapeutics, Volatility, Coya Therapeutics, History as well as Coya Therapeutics, Performance.
  
Please specify Coya Therapeutics,'s target price for which you would like Coya Therapeutics, odds to be computed.

Coya Therapeutics, Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Coya Therapeutics, for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Coya Therapeutics, Common can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Coya Therapeutics, had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 6 M. Net Loss for the year was (7.99 M) with profit before overhead, payroll, taxes, and interest of 0.
Coya Therapeutics, generates negative cash flow from operations
Coya Therapeutics, has a frail financial position based on the latest SEC disclosures

Coya Therapeutics, Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Coya Stock often depends not only on the future outlook of the current and potential Coya Therapeutics,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Coya Therapeutics,'s indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding10.2 M
Cash And Short Term Investments32.6 M

Coya Therapeutics, Technical Analysis

Coya Therapeutics,'s future price can be derived by breaking down and analyzing its technical indicators over time. Coya Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Coya Therapeutics, Common. In general, you should focus on analyzing Coya Stock price patterns and their correlations with different microeconomic environments and drivers.

Coya Therapeutics, Predictive Forecast Models

Coya Therapeutics,'s time-series forecasting models is one of many Coya Therapeutics,'s stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Coya Therapeutics,'s historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Coya Therapeutics, Common

Checking the ongoing alerts about Coya Therapeutics, for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Coya Therapeutics, Common help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Coya Therapeutics, had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 6 M. Net Loss for the year was (7.99 M) with profit before overhead, payroll, taxes, and interest of 0.
Coya Therapeutics, generates negative cash flow from operations
Coya Therapeutics, has a frail financial position based on the latest SEC disclosures
When determining whether Coya Therapeutics, Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Coya Therapeutics,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Coya Therapeutics, Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Coya Therapeutics, Common Stock:
Check out Coya Therapeutics, Backtesting, Coya Therapeutics, Valuation, Coya Therapeutics, Correlation, Coya Therapeutics, Hype Analysis, Coya Therapeutics, Volatility, Coya Therapeutics, History as well as Coya Therapeutics, Performance.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Coya Therapeutics,. If investors know Coya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Coya Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Coya Therapeutics, Common is measured differently than its book value, which is the value of Coya that is recorded on the company's balance sheet. Investors also form their own opinion of Coya Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Coya Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Coya Therapeutics,'s market value can be influenced by many factors that don't directly affect Coya Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Coya Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Coya Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Coya Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.